News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
64,678 Results
Type
Article (1707)
Company Profile (121)
Press Release (62849)
Section
Business (30038)
Career Advice (41)
Deals (4283)
Drug Delivery (2)
Drug Development (7077)
Employer Resources (10)
FDA (1340)
Job Trends (1652)
News (40772)
Policy (2095)
Tag
Academia (146)
Accelerated approval (2)
Allergies (16)
Alliances (2273)
ALS (4)
Alzheimer's disease (111)
Antibody-drug conjugate (ADC) (26)
Approvals (1405)
Artificial intelligence (31)
Autoimmune disease (5)
Bankruptcy (20)
Best Places to Work (1638)
Biosimilars (6)
Biotechnology (55)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (96)
Cancer (514)
Cardiovascular disease (35)
Career advice (38)
Career pathing (1)
CAR-T (15)
Cell therapy (45)
Cervical cancer (8)
Clinical research (6624)
Collaboration (71)
Compensation (74)
Complete response letters (2)
COVID-19 (148)
CRISPR (2)
C-suite (15)
Cystic fibrosis (11)
Data (674)
Depression (4)
Diabetes (36)
Diagnostics (781)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (9)
Drug pricing (5)
Duchenne muscular dystrophy (12)
Earnings (27679)
Employer branding (3)
Employer resources (8)
Events (6650)
Executive appointments (23)
FDA (1768)
Frontotemporal dementia (2)
Funding (55)
Gene editing (5)
Generative AI (4)
Gene therapy (45)
GLP-1 (79)
Government (255)
Guidances (236)
Healthcare (1912)
HIV (7)
IgA nephropathy (9)
Immunology and inflammation (14)
Immuno-oncology (2)
Indications (9)
Infectious disease (160)
Inflammatory bowel disease (20)
Influenza (5)
Intellectual property (10)
Interviews (2)
IPO (3328)
IRA (2)
Job creations (138)
Job search strategy (35)
Kidney cancer (3)
Labor market (11)
Layoffs (38)
Leadership (2)
Legal (322)
Liver cancer (3)
Lung cancer (101)
Lymphoma (53)
Management (3)
Manufacturing (22)
MASH (18)
Medical device (1762)
Medtech (1767)
Mergers & acquisitions (1021)
Metabolic disorders (90)
Multiple sclerosis (25)
NASH (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (7)
Neuroscience (190)
NextGen: Class of 2025 (560)
Non-profit (249)
Now hiring (1)
Obesity (39)
Opinion (5)
Ovarian cancer (5)
Pain (17)
Pancreatic cancer (16)
Parkinson's disease (15)
Partnered (3)
Patents (18)
Patient recruitment (14)
Peanut (7)
People (1888)
Pharmaceutical (41)
Pharmacy benefit managers (2)
Phase I (1425)
Phase II (2673)
Phase III (2922)
Pipeline (970)
Policy (5)
Postmarket research (326)
Preclinical (401)
Press Release (8)
Prostate cancer (16)
Radiopharmaceuticals (22)
Rare diseases (49)
Real estate (201)
Recruiting (3)
Regulatory (1818)
Reports (14)
Research institute (116)
Resumes & cover letters (4)
Rett syndrome (4)
RSV (5)
Schizophrenia (14)
Series A (5)
Series B (6)
Service/supplier (5)
Sickle cell disease (10)
Special edition (4)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (129)
Stomach cancer (2)
Supply chain (2)
Tariffs (1)
The Weekly (1)
Vaccines (57)
Venture capital (1)
Weight loss (17)
Women's health (4)
Worklife (1)
Date
Today (20)
Last 7 days (100)
Last 30 days (251)
Last 365 days (4272)
2025 (3292)
2024 (4908)
2023 (5312)
2022 (6085)
2021 (6326)
2020 (5585)
2019 (4311)
2018 (3306)
2017 (2877)
2016 (1993)
2015 (2948)
2014 (2065)
2013 (1628)
2012 (1732)
2011 (1820)
2010 (1770)
Location
Africa (51)
Alabama (7)
Arizona (28)
Arkansas (1)
Asia (4520)
Australia (402)
California (1140)
Canada (354)
China (113)
Colorado (61)
Connecticut (51)
Delaware (52)
Europe (8821)
Florida (165)
Georgia (38)
Idaho (4)
Illinois (66)
India (10)
Indiana (97)
Iowa (1)
Japan (55)
Kansas (13)
Kentucky (2)
Louisiana (7)
Maine (39)
Maryland (168)
Massachusetts (841)
Michigan (34)
Minnesota (104)
Missouri (8)
Montana (12)
Nevada (15)
New Hampshire (14)
New Jersey (553)
New Mexico (2)
New York (332)
North Carolina (188)
Northern California (587)
Ohio (26)
Oregon (5)
Pennsylvania (273)
Rhode Island (2)
South America (90)
South Carolina (2)
Southern California (412)
Tennessee (8)
Texas (133)
United States (4523)
Utah (34)
Virginia (11)
Washington D.C. (4)
Washington State (103)
Wisconsin (10)
64,678 Results for "54".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncology Market Poised to Reach USD 600.97 Billion by 2034, Growing at 11.54% CAGR
September 22, 2025
·
1 min read
Press Releases
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
October 9, 2025
·
5 min read
Press Releases
Analytical Instrumentation Market Size to Expected USD 97.54 Billion by 2034
July 21, 2025
·
1 min read
Press Releases
Next-Generation AI in Life Sciences Market Sees 54% Uptake by Biopharma in 2025
July 22, 2025
·
1 min read
Press Releases
Breast Cancer Market Size Worth USD 38.54 Bn by 2034
July 9, 2025
·
1 min read
Press Releases
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
October 9, 2025
·
14 min read
Press Releases
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
October 9, 2025
·
14 min read
Press Releases
Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service
October 2, 2025
·
4 min read
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain episodes in patients with sickle cell disease over the 48-week treatment period.
August 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cell and Gene Therapy Clinical Trials Market Size Expected to Hit USD 54.29 Bn by 2034
August 7, 2025
·
1 min read
1 of 6,468
Next
